Brought to you by 
OvaScience brings in $37mm through its Series B venture round; adds $3.6mm
25 Jul 2012
Executive Summary
OvaScience (reproductive medicine) has raised $37mm through its Series B venture round. General Catalyst led (and contributes one board member) and was joined by fellow new backers BBT Capital Management, Cycad Group, Hunt BioVentures, and RA Capital as well as current shareholders Bessemer Venture Partners and Longwood Fund. Leerink Swann was the placement agent.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OvaScience brings in $37mm through its Series B venture round; adds $3.6mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice